These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28502727)

  • 1. Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study.
    Rasmussen-Torvik LJ; Almoguera B; Doheny KF; Freimuth RR; Gordon AS; Hakonarson H; Hawkins JB; Husami A; Ivacic LC; Kullo IJ; Linderman MD; Manolio TA; Obeng AO; Pellegrino R; Prows CA; Ritchie MD; Smith ME; Stallings SC; Wolf WA; Zhang K; Scott SA
    J Mol Diagn; 2017 Jul; 19(4):561-566. PubMed ID: 28502727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of next generation sequencing based HLA typing for disease association and pharmacogenetic testing.
    Profaizer T; Pole A; Monds C; Delgado JC; Lázár-Molnár E
    Hum Immunol; 2020 Jul; 81(7):354-360. PubMed ID: 32499099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
    Suzuki O; Dong OM; Howard RM; Wiltshire T
    Pharmacogenomics; 2019 Sep; 20(14):1005-1020. PubMed ID: 31559919
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
    Ng D; Hong CS; Singh LN; Johnston JJ; Mullikin JC; Biesecker LG
    Genet Med; 2017 Mar; 19(3):357-361. PubMed ID: 27537706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Next-Generation Sequencing for Human Leukocyte Antigen Typing in a Clinical Laboratory: Metrics of Relevance and Considerations for Its Successful Implementation.
    Gandhi MJ; Ferriola D; Huang Y; Duke JL; Monos D
    Arch Pathol Lab Med; 2017 Jun; 141(6):806-812. PubMed ID: 28234015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2024 Oct; 26(10):851-863. PubMed ID: 39032821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping.
    Parkin NT; Avila-Rios S; Bibby DF; Brumme CJ; Eshleman SH; Harrigan PR; Howison M; Hunt G; Ji H; Kantor R; Ledwaba J; Lee ER; Matías-Florentino M; Mbisa JL; Noguera-Julian M; Paredes R; Rivera-Amill V; Swanstrom R; Zaccaro DJ; Zhang Y; Zhou S; Jennings C
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32605062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing.
    Ozaki Y; Suzuki S; Kashiwase K; Shigenari A; Okudaira Y; Ito S; Masuya A; Azuma F; Yabe T; Morishima S; Mitsunaga S; Satake M; Ota M; Morishima Y; Kulski JK; Saito K; Inoko H; Shiina T
    BMC Genomics; 2015 Apr; 16(1):318. PubMed ID: 25895492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type.
    Moyer AM; Dukek B; Duellman P; Schneider B; Wakefield L; Skierka JM; Avula R; Bhagwate AV; Kalari KR; Kreuter JD; Goetz MP; Boughey JC; Black JL; Gandhi MJ
    Hum Immunol; 2020 Aug; 81(8):423-429. PubMed ID: 32546429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrogating Pharmacogenetics Using Next-Generation Sequencing.
    Ji Y; Shaaban S
    J Appl Lab Med; 2024 Jan; 9(1):50-60. PubMed ID: 38167765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Analytical Validation of a 29 Gene Clinical Pharmacogenetic Genotyping Panel: Multi-Ethnic Allele and Copy Number Variant Detection.
    Scott SA; Scott ER; Seki Y; Chen AJ; Wallsten R; Owusu Obeng A; Botton MR; Cody N; Shi H; Zhao G; Brake P; Nicoletti P; Yang Y; Delio M; Shi L; Kornreich R; Schadt EE; Edelmann L
    Clin Transl Sci; 2021 Jan; 14(1):204-213. PubMed ID: 32931151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO genotyping with next-generation sequencing to resolve heterogeneity in donors with serology discrepancies.
    Wu PC; Lin YH; Tsai LF; Chen MH; Chen PL; Pai SC
    Transfusion; 2018 Sep; 58(9):2232-2242. PubMed ID: 29770457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for comprehensive pharmacogenetic genotyping platforms.
    Lauschke VM; Ingelman-Sundberg M
    Pharmacogenomics; 2016 Jun; 17(8):917-24. PubMed ID: 27248710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next generation sequencing for human papillomavirus genotyping.
    Arroyo LS; Smelov V; Bzhalava D; Eklund C; Hultin E; Dillner J
    J Clin Virol; 2013 Oct; 58(2):437-42. PubMed ID: 23932809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational pharmacogenotype extraction from clinical next-generation sequencing.
    Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
    Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing low-pass sequencing and genotyping for trait mapping in pharmacogenetics.
    Wasik K; Berisa T; Pickrell JK; Li JH; Fraser DJ; King K; Cox C
    BMC Genomics; 2021 Mar; 22(1):197. PubMed ID: 33743587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus genotyping by 454 next generation sequencing technology.
    Barzon L; Militello V; Lavezzo E; Franchin E; Peta E; Squarzon L; Trevisan M; Pagni S; Dal Bello F; Toppo S; Palù G
    J Clin Virol; 2011 Oct; 52(2):93-7. PubMed ID: 21802982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.